Spotlight on comorbidities in STEMI patients

Mortality for myocardial infarction is at its lowest historical level for 20 years, but comorbidities such as anemia, renal failure and hyperglycemia seem the next frontier to investigate their impact as risk modifiers mortality in acute myocardial infarction. Stress hyperglycemia is a very frequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruno, Raphael Romano, Kelm, Malte, Jung, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947710/
https://www.ncbi.nlm.nih.gov/pubmed/31922029
http://dx.doi.org/10.1002/edm2.102
Descripción
Sumario:Mortality for myocardial infarction is at its lowest historical level for 20 years, but comorbidities such as anemia, renal failure and hyperglycemia seem the next frontier to investigate their impact as risk modifiers mortality in acute myocardial infarction. Stress hyperglycemia is a very frequent problem in STEMI, but continuous insulin infusion therapy (CIIT) resulted in >threefold and >twofold increased risks in‐hospital and 1‐year mortality, respectively.[Image: see text]

Ejemplares similares